vs

Side-by-side financial comparison of SeaStar Medical Holding Corp (ICU) and Sintx Technologies, Inc. (SINT). Click either name above to swap in a different company.

SeaStar Medical Holding Corp is the larger business by last-quarter revenue ($420.0K vs $290.0K, roughly 1.4× Sintx Technologies, Inc.). SeaStar Medical Holding Corp runs the higher net margin — -691.4% vs -763.8%, a 72.4% gap on every dollar of revenue. On growth, SeaStar Medical Holding Corp posted the faster year-over-year revenue change (526.9% vs -46.5%).

ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...

Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.

ICU vs SINT — Head-to-Head

Bigger by revenue
ICU
ICU
1.4× larger
ICU
$420.0K
$290.0K
SINT
Growing faster (revenue YoY)
ICU
ICU
+573.4% gap
ICU
526.9%
-46.5%
SINT
Higher net margin
ICU
ICU
72.4% more per $
ICU
-691.4%
-763.8%
SINT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ICU
ICU
SINT
SINT
Revenue
$420.0K
$290.0K
Net Profit
$-2.9M
$-2.2M
Gross Margin
97.1%
64.8%
Operating Margin
-718.6%
-799.3%
Net Margin
-691.4%
-763.8%
Revenue YoY
526.9%
-46.5%
Net Profit YoY
34.3%
-30.7%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICU
ICU
SINT
SINT
Q4 25
$420.0K
$290.0K
Q3 25
$183.0K
$208.0K
Q2 25
$338.0K
$151.0K
Q1 25
$293.0K
$369.0K
Q4 24
$67.0K
$542.0K
Q3 24
$68.0K
$799.0K
Q2 24
$0
$859.0K
Q1 24
$0
$687.0K
Net Profit
ICU
ICU
SINT
SINT
Q4 25
$-2.9M
$-2.2M
Q3 25
$-3.5M
$-3.5M
Q2 25
$-2.0M
$-2.3M
Q1 25
$-3.8M
$-2.3M
Q4 24
$-4.4M
$-1.7M
Q3 24
$-4.5M
$-6.2M
Q2 24
$-3.2M
$-2.2M
Q1 24
$-12.7M
$-886.0K
Gross Margin
ICU
ICU
SINT
SINT
Q4 25
97.1%
64.8%
Q3 25
92.3%
44.7%
Q2 25
92.0%
37.7%
Q1 25
100.0%
33.3%
Q4 24
100.0%
71.6%
Q3 24
100.0%
73.7%
Q2 24
73.9%
Q1 24
67.5%
Operating Margin
ICU
ICU
SINT
SINT
Q4 25
-718.6%
-799.3%
Q3 25
-1955.7%
-1613.0%
Q2 25
-519.5%
-1764.9%
Q1 25
-1304.4%
-645.8%
Q4 24
-7114.9%
-319.6%
Q3 24
-6552.9%
-802.0%
Q2 24
-315.5%
Q1 24
-465.4%
Net Margin
ICU
ICU
SINT
SINT
Q4 25
-691.4%
-763.8%
Q3 25
-1897.3%
-1701.4%
Q2 25
-592.3%
-1535.1%
Q1 25
-1287.4%
-621.1%
Q4 24
-6595.5%
-312.7%
Q3 24
-6585.3%
-780.9%
Q2 24
-256.6%
Q1 24
-129.0%
EPS (diluted)
ICU
ICU
SINT
SINT
Q4 25
$-0.50
Q3 25
$-3.46
Q2 25
$-0.18
$-0.91
Q1 25
$-0.44
$-1.29
Q4 24
$0.23
$17.04
Q3 24
$-1.10
$-6.96
Q2 24
$-1.03
$-3.61
Q1 24
$-4.73
$-21.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICU
ICU
SINT
SINT
Cash + ST InvestmentsLiquidity on hand
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$10.4M
$2.9M
Total Assets
$14.2M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICU
ICU
SINT
SINT
Q4 25
$4.1M
Q3 25
$6.3M
Q2 25
$4.3M
Q1 25
$6.5M
Q4 24
$3.6M
Q3 24
$4.8M
Q2 24
$4.6M
Q1 24
$5.8M
Total Debt
ICU
ICU
SINT
SINT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$0
Q1 24
$1.1M
Stockholders' Equity
ICU
ICU
SINT
SINT
Q4 25
$10.4M
$2.9M
Q3 25
$11.5M
$4.1M
Q2 25
$3.3M
$4.0M
Q1 25
$565.0K
$6.1M
Q4 24
$-2.2M
$3.9M
Q3 24
$-2.1K
$5.6M
Q2 24
$-6.9M
$8.8M
Q1 24
$-4.5M
$9.9M
Total Assets
ICU
ICU
SINT
SINT
Q4 25
$14.2M
$9.5M
Q3 25
$15.5M
$11.4M
Q2 25
$8.4M
$9.2M
Q1 25
$7.6M
$11.4M
Q4 24
$4.7M
$9.4M
Q3 24
$4.6M
$11.3M
Q2 24
$3.5M
$15.3M
Q1 24
$7.7M
$17.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICU
ICU
SINT
SINT
Operating Cash FlowLast quarter
$-4.1M
$-2.3M
Free Cash FlowOCF − Capex
$-2.4M
FCF MarginFCF / Revenue
-822.8%
Capex IntensityCapex / Revenue
14.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICU
ICU
SINT
SINT
Q4 25
$-4.1M
$-2.3M
Q3 25
$-3.8M
$-2.5M
Q2 25
$-3.0M
$-2.4M
Q1 25
$-2.7M
$-1.3M
Q4 24
$-4.7M
$-1.1M
Q3 24
$-5.0M
$-2.6M
Q2 24
$-2.8M
$-2.2M
Q1 24
$-3.5M
$-2.7M
Free Cash Flow
ICU
ICU
SINT
SINT
Q4 25
$-2.4M
Q3 25
$-2.6M
Q2 25
Q1 25
$-1.4M
Q4 24
$-1.3M
Q3 24
$-2.6M
Q2 24
$-2.6M
Q1 24
$-2.9M
FCF Margin
ICU
ICU
SINT
SINT
Q4 25
-822.8%
Q3 25
-1250.5%
Q2 25
Q1 25
-368.6%
Q4 24
-234.3%
Q3 24
-323.0%
Q2 24
-299.7%
Q1 24
-423.1%
Capex Intensity
ICU
ICU
SINT
SINT
Q4 25
14.5%
Q3 25
40.4%
Q2 25
0.0%
Q1 25
16.0%
Q4 24
26.9%
Q3 24
1.4%
Q2 24
41.8%
Q1 24
25.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons